Table 2.
Clinical presentation of patients who were admitted for cardiac catheterization during the pandemic-related lockdown period and non-pandemic period
| Clinical presentation | 2019 | 2020 | Change % (95% CI)1 | p value1 |
|---|---|---|---|---|
| CCS, n | 2008 | 1112 | 44.6 (40.4–48.5) | < 0.001 |
| ACS, n | 1061 | 860 | 18.9 (11.3–25.9) | < 0.001 |
| NSTE-ACS, n | 750 | 560 | 25.3 (16.7–33.1) | < 0.001 |
| STEMI, n | 311 | 300 | 3.5 (0–17.7) | 0.656 |
| OHCA, n | 69 | 58 | 15.9(0–40.7) | 0.330 |
| Procedural characteristics | 2019 | 2020 | p-value2 | |
| PCI, n (%) | 1173/2084 (56) | 687/1290 (53) | 0.163 | |
| LM PCI, n (%) | 91/1725 (5) | 51/1080 (5) | 0.516 | |
| CTO-PCI, n (%) | 67/1727 (4) | 54/1079 (5) | 0.153 | |
| Bifurcation-PCI, n (%) | 79/1724 (5) | 47/1080 (4) | 0.774 | |
| Door to balloon Time (STEMI), median (IQR) | 36 (25–52.5) | 34 (25–59.8) | 0.7833 |
Tests used: 1Poisson regression; 2Pearson X2 test; 3Wilcoxon test
ACS acute coronary syndrome, CCS Chronic coronary syndrome, LM: left main, NSTE-ACS acute coronary syndrome without ST-elevation, OHCA out-of-hospital cardiac arrest, PCI percutaneous coronary intervention, STEMI ST-elevation myocardial infarction